Biotech Values

[swampboots]

DEW: I am sure you already posted, but the wrong impression can be obtained from the passage below. Kindly reference the type of improvement (of the Visudyne protocol) ie. lines etc.

<Approval was based on the results of a well-designed 12-month clinical study conducted in Japan, which confirmed the efficacy and safety profile of Visudyne as demonstrated in 3 large randomized controlled trials conducted in the rest of the world. In fact, approximately 3 patients out of 4 participating in this study either maintained or improved their vision as a result of Visudyne therapy>